# PAVmed Inc. (PAVM)

Source: https://www.quantisnow.com/company/PAVM
Generated: 2026-11-22T05:04:44.634Z

- Ticker: PAVM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2016
- SEC CIK: 0001624326
- Website: pavmed.com

## About

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

## Latest PAVM news and filings

- 2026-11-13 13:05 UTC [SEC Form 8-K] [PAVmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/pavmed-inc-filed-sec-form-8-k-results-of-operations-and-6789473)
- 2026-11-13 13:00 UTC [Earnings] [PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/pavmed-provides-business-update-and-reports-preliminary-third-quarter-2026-6789453)
- 2026-11-12 13:00 UTC [Earnings] [Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/lucid-diagnostics-provides-business-update-and-reports-third-quarter-2026-6786527)
- 2026-11-05 13:25 UTC [Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year](https://www.quantisnow.com/insight/lucid-diagnostics-recognized-as-a-genomeweb-best-place-to-work-6774974)
- 2026-11-04 13:55 UTC [Conference Announcement] [Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum](https://www.quantisnow.com/insight/lucid-diagnostics-to-participate-in-the-canaccord-genuity-medtech-diagnostics-6771617)
- 2026-11-03 21:35 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by PAVmed Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-pavmed-inc-6770166)
- 2026-11-03 13:15 UTC [Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study](https://www.quantisnow.com/insight/lucid-diagnostics-announces-publication-of-landmark-12000-patient-real-world-esoguard-study-6768655)
- 2026-10-30 12:30 UTC [Earnings Date] [PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026](https://www.quantisnow.com/insight/pavmed-to-hold-third-quarter-2026-business-update-conference-call-6764685)
- 2026-10-29 12:30 UTC [Earnings Date] [Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026](https://www.quantisnow.com/insight/lucid-diagnostics-to-hold-third-quarter-2026-business-update-conference-6762799)
- 2026-10-22 21:28 UTC [SEC Form 8-K] [SEC Form 8-K filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-pavmed-inc-6755563)
- 2026-10-22 20:20 UTC [Dividends] [Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing](https://www.quantisnow.com/insight/lucid-diagnostics-begins-receiving-medicare-reimbursement-for-esoguard-and-closes-6755269)
- 2026-09-22 11:55 UTC [Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways](https://www.quantisnow.com/insight/lucid-diagnostics-advances-multiple-esoguard-and-esocheck-payment-billing-and-6722362)
- 2026-09-09 23:15 UTC [SEC Form 8-K] [PAVmed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/pavmed-inc-filed-sec-form-8-k-entry-into-a-material-6710661)
- 2026-08-14 14:44 UTC [SEC Form 8-K] [PAVmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/pavmed-inc-filed-sec-form-8-k-results-of-operations-and-6682342)
- 2026-08-14 12:00 UTC [Earnings Date] [PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/pavmed-provides-business-update-and-reports-second-quarter-2026-financial-6681878)
- 2026-08-13 23:21 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by PAVmed Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-pavmed-inc-6681524)
- 2026-08-13 21:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-pavmed-inc-6681197)
- 2026-08-13 12:00 UTC [Earnings Date] [Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/lucid-diagnostics-provides-business-update-and-reports-second-quarter-2026-6679418)
- 2026-08-05 12:46 UTC [Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test](https://www.quantisnow.com/insight/lucid-diagnostics-secures-commercial-coverage-policy-spanning-multiple-health-plans-6664265)
- 2026-08-04 12:30 UTC [Conference Announcement] [Lucid Diagnostics to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-6661325)
- 2026-07-31 12:30 UTC [Earnings Date] [PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026](https://www.quantisnow.com/insight/pavmed-to-hold-second-quarter-2026-business-update-conference-call-6657274)
- 2026-07-30 12:30 UTC [Earnings Date] [Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026](https://www.quantisnow.com/insight/lucid-diagnostics-to-hold-second-quarter-2026-business-update-conference-6655274)
- 2026-07-30 00:09 UTC [SEC Form S-8] [SEC Form S-8 filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-pavmed-inc-6654606)
- 2026-06-24 21:00 UTC [SEC Form 8-K] [PAVmed Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/pavmed-inc-filed-sec-form-8-k-leadership-update-submission-of-6614524)
- 2026-05-15 12:05 UTC [SEC Form 8-K] [PAVmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/pavmed-inc-filed-sec-form-8-k-results-of-operations-and-6555818)
- 2026-05-15 12:00 UTC [Public Offering] [PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/pavmed-provides-business-update-and-reports-first-quarter-2026-financial-6555772)
- 2026-05-14 21:17 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-pavmed-inc-6554829)
- 2026-05-14 20:33 UTC [SEC Form SCHEDULE 13G filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-pavmed-inc-6554468)
- 2026-05-14 12:00 UTC [Public Offering] [Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/lucid-diagnostics-provides-business-update-and-reports-first-quarter-2026-6552524)
- 2026-05-01 13:28 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-pavmed-inc-6526150)
- 2026-05-01 12:31 UTC [Earnings Date] [PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026](https://www.quantisnow.com/insight/pavmed-to-hold-first-quarter-2026-business-update-conference-call-6526026)
- 2026-04-30 21:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-pavmed-inc-6525324)
- 2026-04-30 12:31 UTC [Earnings Date] [Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026](https://www.quantisnow.com/insight/lucid-diagnostics-to-hold-first-quarter-2026-business-update-conference-6523158)
- 2026-04-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-pavmed-inc-6522357)
- 2026-04-29 20:15 UTC [SEC Form 424B3] [SEC Form 424B3 filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-pavmed-inc-6521428)
- 2026-04-24 14:23 UTC [Public Offering] [Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock](https://www.quantisnow.com/insight/lucid-diagnostics-announces-closing-of-18-million-underwritten-offering-of-6513899)
- 2026-04-23 12:30 UTC [Public Offering] [Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock](https://www.quantisnow.com/insight/lucid-diagnostics-announces-18-million-underwritten-offering-of-common-stock-6511815)
- 2026-04-21 01:17 UTC [SEC Form S-3] [SEC Form S-3 filed by PAVmed Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-pavmed-inc-6507391)
- 2026-04-13 20:10 UTC [SEC Form 4] [SEC Form 4 filed by Lee Victoria Tou-Ho](https://www.quantisnow.com/insight/sec-form-4-filed-by-lee-victoria-tou-ho-6497870)
- 2026-04-13 20:07 UTC [SEC Form 3] [SEC Form 3 filed by new insider Lee Victoria Tou-Ho](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-lee-victoria-tou-ho-6497852)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PAVM
- Earnings history: https://www.quantisnow.com/earnings/PAVM
- Dividend history: https://www.quantisnow.com/dividends/PAVM
- Insider transactions: https://www.quantisnow.com/insiders/PAVM
- Options chain: https://www.quantisnow.com/options/PAVM
- SEC 8-K filings only: https://www.quantisnow.com/company/PAVM/8-k
- RSS and alerts for PAVM: https://www.quantisnow.com/docs/rss-feeds.md
